Evidence map›Paper›PMID 40838213›Full record

ReviewMaterials today. Bio2025

Innovative nanocarriers: Synthetic and biomimetic strategies for enhanced drug delivery.

Runzi Guo, Zhenzhen Zhang, Shuyi Zhang, Tingting Gai, Huizhu Yu, Li Su, Heng Yin, Xiuhui Wang, Yafeng Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Is Emerging Nanomedicine a Friend or Foe to Germ Cells?International journal of nanomedicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Runzi GuoInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Zhenzhen ZhangInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Shuyi ZhangInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Tingting GaiInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Huizhu YuSchool of Chemistry & Materials Engineering, Fuyang Normal University, Fuyang, 236037, China.
Li SuInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Heng YinJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, 214071, China.
Xiuhui WangInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Yafeng ZhangJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, 214071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective drug delivery plays a vital role in the treatment of various biomedical conditions. Application of innovative nanocarriers could address issues faced in drug delivery such as poor drug distribution, inefficient penetration across biological barriers, targeting and security. With the development of nanotechnology, the preparation approaches, structures and properties of nanocarriers are continuously improving, while the comparison of detailed construction strategies and corresponding innovative application of different nanocarriers for enhanced drug delivery are few. In this review, innovative nanocarriers including synthetic nanocarriers with different shapes and biomimetic nanocarriers inspired by different biological sources are introduced. Moreover, the multi-functionalities and advancements of nanocarriers in drug delivery are intensively discussed. Finally, we outline the current limitations and future perspectives of nanocarriers efforts in drug delivery, with a focus on their key challenges from bench to bedside.

Indexed as

Biomimetic nanocarriersDisease treatmentsDrug deliveryMultifuctionalitiesSynthetic nanocarriersVarious shapes

Identifiers

PMID40838213
PMCPMC12362117

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.